This morning I added to my investment in the Lyxor
(2809) at $17.42. The purchase was partly motivated by the very early and tentative signs of recovery in manufacturing in China. The greater, but more speculative motivation, was a realisation that the huge run down in inventory levels should be reversed (at least in part) as demand for manufactured goods bottoms out.
Post a Comment